PACBiomarker1 paperHuman trial1FundingNational Cancer InstituteUS$646.2k1 grant since 2023The Pacific Aging and Cancer Studies (PACS): An Infrastructure Advancing the Use of Digital Biomarkers and Related Technologies for Research on Functional Aging and Survivorship in CancerNational Cancer InstituteOregon Health & Science UniversityUS$646.2k2023–2028LatestNov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 01Nature BiotechnologyHuman trial·8 SepIntegration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessmentBiomarkers
Nature BiotechnologyHuman trial·8 SepIntegration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessmentBiomarkers